References

Unresolved reference

2025 · External reference

Cell-free DNA as a complementary diagnostic tool for neglected tropical diseases towards achieving the WHO NTDs elimination by 2030

10.1016/j.jlb.2024.100283 · 2025 · External reference

Recent advancements in the diagnosis of parasitic diseases

10.1016/j.molbiopara.2025.111706 · 2025 · External reference

Artificial intelligence in malaria: advances in diagnostic, therapeutic, and surveillance applications for smart health systems

2026 · External reference

Revolution in malaria detection: unveiling current breakthroughs and tomorrow's possibilities in biomarker innovation

10.1097/ms9.0000000000002383 · 2024 · External reference

The spectrum of clinical biomarkers in severe malaria and new avenues for exploration

10.1080/21505594.2022.2056966 · 2022 · External reference

Early detection of infectious diseases: a review of recent advances in pathogen identification, molecular tools, and metabolomics-driven biomarker discovery

2025 · External reference

Schistosomiasis related circulating cell-free DNA: a useful biomarker in diagnostics

10.1016/j.molbiopara.2022.111495 · 2022 · External reference

Circulating cell-free nucleic acids: main characteristics and clinical application

10.3390/ijms21186827 · 2020 · External reference

Cell-free DNA: a promising biomarker in infectious diseases

10.1016/j.tim.2024.06.005 · 2025 · External reference

The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature

10.1111/brv.12413 · 2018 · External reference

Plasma cell-free DNA predicts pediatric cerebral malaria severity

10.1172/jci.insight.136279 · 2020 · External reference

Cell-free DNA as a diagnostic tool for human echinococcosis

10.1016/j.pt.2021.07.006 · 2021 · External reference

Diagnosis of echinococcosis by detecting circulating cell-free DNA and miRNA

10.1080/14737159.2023.2178903 · 2023 · External reference

Spectral flow cytometry for detecting DNA cargo in malaria parasite–derived extracellular vesicles

10.1016/j.jbc.2025.108481 · 2025 · External reference

Diagnostic and prognostic value of cell free circulating Schistosoma mansoni DNA: an experimental study

10.1007/s12639-014-0626-0 · 2016 · External reference

Circulating cell-free DNA as a biomarker for molecular diagnosis of Neurocysticercosis

10.1016/j.jns.2024.123039 · 2024 · External reference

Targeted sequencing of genomic repeat regions detects circulating cell-free Echinococcus DNA

10.1371/journal.pntd.0008147 · 2020 · External reference

Experimental study for early diagnosis of prepatent schistosomiasis mansoni by detection of free circulating DNA in serum

10.1007/s00436-012-2822-0 · 2012 · External reference

Cell-free DNA as a diagnostic tool for human parasitic infections

10.1016/j.pt.2016.01.006 · 2016 · External reference

Technical advances in circulating cell-free DNA detection and analysis for personalized medicine in patients' care

10.3390/biom14040498 · 2024 · External reference

Fragmentation patterns of pathogen-derived cell-free DNA as a promising non-invasive biomarker for bloodstream infection diagnosis

2025 · External reference

Digital PCR: modern solution to parasite diagnostics and population trait genetics

10.1186/s13071-023-05756-7 · 2023 · External reference

Extracellular vesicles, from pathogenesis to biomarkers: the case for cerebral malaria

2020 · External reference

Extracellular vesicles released by anaerobic protozoan parasites: current situation

10.1111/cmi.13257 · 2020 · External reference

Biogenesis of extracellular vesicles from the pathogen perspective: transkingdom strategies for delivering messages

10.1016/j.ceb.2024.102366 · 2024 · External reference

Guidelines for the purification and characterization of extracellular vesicles of parasites

10.1002/jex2.117 · 2023 · External reference

Release of small RNA-containing exosome-like vesicles from the human filarial parasite Brugia malayi

10.1371/journal.pntd.0004069 · 2015 · External reference

Proteomic profiling of serum extracellular vesicles identifies diagnostic markers for echinococcosis

10.1371/journal.pntd.0010814 · 2022 · External reference

Extracellular vesicles in parasitic diseases – from pathogenesis to future diagnostic tools

10.1016/j.micinf.2024.105310 · 2024 · External reference

Extracellular vesicles from parasitic helminths and their potential utility as vaccines

10.1080/14760584.2018.1431125 · 2018 · External reference

Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy

10.1002/wnan.1835 · 2023 · External reference

Sending a message: extracellular vesicles of pathogenic protozoan parasites

10.1038/nrmicro.2016.110 · 2016 · External reference

Characterization and diagnostic application of trypanosoma cruzi trypomastigote excreted-secreted antigens shed in extracellular vesicles released from infected mammalian cells

10.1128/jcm.01649-16 · 2017 · External reference

Integrating aggregate materials and machine learning algorithms: advancing detection of pathogen-derived extracellular vesicles

2025 · External reference

MicroRNAs: master regulators in host-parasitic protist interactions

10.1098/rsob.210395 · 2022 · External reference

Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach

2024 · External reference

Human microRNAs in host–parasite interaction: a review

10.1007/s13205-020-02498-6 · 2020 · External reference

Non-coding RNAs in malaria infection

10.1002/wrna.1697 · 2022 · External reference

Modulation of host-parasite interactions with small molecules targeting Schistosoma mansoni microRNAs

10.1021/acsinfecdis.2c00360 · 2022 · External reference

Liquid biopsy for promising non-invasive diagnostic biomarkers in parasitic infections

10.1007/s11686-021-00444-x · 2022 · External reference

Host–parasite interactions mediated by cross-species microRNAs

10.1016/j.pt.2022.02.011 · 2022 · External reference

Alterations of plasma circulating microRNAs in BALB/c mice with Toxocara canis visceral and cerebral larva migrans

10.1186/s13071-024-06327-0 · 2024 · External reference

The potential role of MicroRNA‐124‐3p in growth, development, and reproduction of Schistosoma japonicum

10.3389/fcimb.2022.862496 · 2022 · External reference

Parasite-derived MicroRNAs in host serum as novel biomarkers of helminth infection

10.1371/journal.pntd.0002701 · 2014 · External reference

Novel miRNA biomarkers for alveolar echinococcosis: sequencing and clinical validation

10.1017/s0031182024001367 · 2024 · External reference

Detecting Fasciola hepatica and Fasciola gigantica microRNAs with loop-mediated isothermal amplification (LAMP)

10.1007/s12639-019-01164-w · 2020 · External reference

Circulating miRNAs: potential novel biomarkers for hepatopathology progression and diagnosis of schistosomiasis japonica in two murine models

10.1371/journal.pntd.0003965 · 2015 · External reference

Circulating microRNAs as potential biomarkers of infectious disease

2017 · External reference

Harnessing the potential of miRNAs in malaria diagnostic and prevention. Front cell infect microbiol

2021 · External reference

Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs

2015 · External reference

Schistosomal microRNAs isolated from extracellular vesicles in sera of infected patients: a new tool for diagnosis and follow-up of human schistosomiasis

2017 · External reference

Plasma-derived exosomal miRNA as potential biomarker for diagnosis and prognosis of vector-borne diseases: a review

10.3389/fmicb.2023.1097173 · 2023 · External reference

Exploring the utility of circulating miRNAs as diagnostic biomarkers of fasciolosis

10.1038/s41598-024-57704-9 · 2024 · External reference

Roles of helminth extracellular vesicle-derived let-7 in host–parasite crosstalk

10.3389/fimmu.2024.1449495 · 2024 · External reference

Plasma-derived parasitic microRNAs have insufficient concentrations to be used as diagnostic biomarker for detection of Onchocerca volvulus infection or treatment monitoring using LNA-based RT-qPCR

10.1007/s00436-017-5382-5 · 2017 · External reference

Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up

10.1016/j.actatropica.2019.105255 · 2020 · External reference

Unveiling novel insights in helminth proteomics: advancements, applications, and implications for parasitology and beyond

10.3390/biologics4030020 · 2024 · External reference

Identification and validation of Loa loa microfilaria-specific biomarkers: a rational design approach using proteomics and novel immunoassays

10.1128/mbio.02132-15 · 2016 · External reference

Pathogen-host interaction mediated by vesicle-based secretion in schistosomes

10.1007/s00709-020-01515-y · 2020 · External reference

Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control

10.1080/14789450.2024.2336994 · 2024 · External reference

A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease

10.1038/s41598-020-76508-1 · 2020 · External reference

Evaluation of six novel antigens as potential biomarkers for the early immunodiagnosis of schistosomiasis

10.1186/s13071-015-1048-2 · 2015 · External reference

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

10.1073/pnas.1501705112 · 2015 · External reference

Patient plasma–based immunoproteomics reveals novel Echinococcus granulosus antigens for diagnosis of cystic echinococcosis

10.1016/j.mcpro.2025.101485 · 2026 · External reference

Antigen discovery, bioinformatics and biological characterization of novel immunodominant Babesia microti antigens

10.1038/s41598-020-66273-6 · 2020 · External reference

Neglected tropical disease (NTD) diagnostics: current development and operations to advance control

10.1080/20477724.2023.2272095 · 2024 · External reference

Advances and strategies in biosensor-based diagnostics for parasitic infections: a comprehensive scoping review

2026 · External reference

Evaluation of Plasmodium falciparum PSSP17 essentiality in human-to-mosquito transmission and its prospective candidacy as a biomarker

10.1016/j.isci.2025.113919 · 2025 · External reference

Cystic echinococcosis microRNAs as potential noninvasive biomarkers: current insights and upcoming perspective

10.1080/14737159.2023.2246367 · 2023 · External reference

Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles directing astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain

2025 · External reference

Toxoplasma gondii inhibits apoptosis via a novel STAT3-miR-17-92-Bim pathway in macrophages

10.1016/j.cellsig.2014.02.013 · 2014 · External reference

MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection

10.1086/653212 · 2010 · External reference

Comparative expression profiles of host circulating miRNAs in response to Trichinella spiralis infection

10.1186/s13567-020-00758-0 · 2020 · External reference

Plasma microRNAs are promising novel biomarkers for the early detection of Toxoplasma gondii infection

10.1186/1756-3305-7-433 · 2014 · External reference

Brain magnetic resonance imaging reveals different courses of disease in pediatric and adult cerebral malaria

10.1093/cid/ciaa1647 · 2021 · External reference

Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group

10.1016/j.parint.2015.10.001 · 2017 · External reference

MicroRNA biomarkers for infectious diseases: from basic research to biosensing

10.3389/fmicb.2020.01197 · 2020 · External reference

Parasitic infections and carcinogenesis: molecular mechanisms, immune modulation, and emerging therapeutic strategies

10.32604/or.2025.071891 · 2026 · External reference

Role of cytokines in immunomodulation during malaria clearance

10.1097/ms9.0000000000002019 · 2024 · External reference

Assessment of Cytokines TNF-alpha, IFN-gamma, TGF-beta-1, and IL-10 in Malaria Patients of the River Nile State, Sudan: a critical study of immune response

10.1186/s12865-025-00753-0 · 2025 · External reference

Immunological biomarkers and their role in the diagnosis and prognosis of leishmaniasis: a case–control study

10.4103/tp.tp_57_24 · 2025 · External reference

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients

10.1371/journal.pntd.0000459 · 2009 · External reference

Advances in the diagnosis of human schistosomiasis

10.1128/cmr.00137-14 · 2015 · External reference

Cytokine profile distinguishes children with plasmodium falciparum malaria from those with bacterial blood stream infections

10.1093/infdis/jiz587 · 2020 · External reference

Systemic cytokine and chemokine profiles in individuals with Schistosoma mansoni infection and low parasite burden

10.3389/fimmu.2018.02975 · 2018 · External reference

Serum proteomics provides novel biomarkers of inflammation, tissue injury, and therapeutic response in experimental chagas disease

10.3390/microorganisms14030588 · 2026 · External reference

Identification of novel diagnostic serum biomarkers for chagas' disease in asymptomatic subjects by mass spectrometric profiling

10.1128/jcm.02207-09 · 2010 · External reference

Preliminary screening of urinary host protein biomarkers for Schistosomiasis haematobium: a proteome profiling study identifying candidate diagnostic targets in school-aged children

10.1371/journal.pntd.0013429 · 2025 · External reference

Plasma proteomics reveals distinct signatures in occult and microfilaremic Loa loa infections

10.1093/infdis/jiaf344 · 2025 · External reference

Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: a study from endemic districts of West Bengal, India

10.1371/journal.pone.0192302 · 2018 · External reference

Review of liquid chromatography-mass spectrometry-based proteomic analyses of body fluids to diagnose infectious diseases

10.3390/ijms23042187 · 2022 · External reference

Proteomic analysis of plasma exosomes from cystic echinococcosis patients provides in vivo support for distinct immune response profiles in active vs inactive infection and suggests potential biomarkers

10.1371/journal.pntd.0008586 · 2020 · External reference

A metabolomic analytical approach permits identification of urinary biomarkers for Plasmodium falciparum infection: a case-control study

10.1186/s12936-017-1875-z · 2017 · External reference

Untargeted serum metabolomics analysis of Trichinella spiralis-infected mouse

10.1371/journal.pntd.0011119 · 2023 · External reference

Metabolomics in infectious diseases and vaccine response: insights into neglected tropical and non-neglected pathogens

10.3390/idr18010010 · 2026 · External reference

Untargeted serum metabolomic profiling for early detection of Schistosoma mekongi infection in mouse model

10.3389/fcimb.2022.910177 · 2022 · External reference

Metabolomics assays applied to schistosomiasis studies: a scoping review

10.1186/s12879-025-10606-1 · 2025 · External reference

Metabolomic analysis of urine samples of vivax malaria in-patients for biomarker identification

10.1007/s11306-015-0791-x · 2015 · External reference

Metabolomics identifies multiple candidate biomarkers to diagnose and stage human African trypanosomiasis

10.1371/journal.pntd.0005140 · 2016 · External reference

Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)

10.1016/j.bmcl.2017.05.082 · 2017 · External reference

Analysis of breath specimens for biomarkers of Plasmodium falciparum infection

10.1093/infdis/jiv176 · 2015 · External reference

Mass spectrometry based metabolomics for small molecule metabolites mining and confirmation as potential biomarkers for schistosomiasis–case of the Okavango Delta communities in Botswana

10.1080/14789450.2021.2012454 · 2022 · External reference

Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents

10.1021/pr901019z · 2010 · External reference

Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria

10.1016/j.ijmm.2017.09.002 · 2017 · External reference

Multimodal biomarker discovery for active Onchocerca volvulus infection

10.1371/journal.pntd.0009999 · 2021 · External reference

High-resolution metabolomics to discover potential parasite-specific biomarkers in a Plasmodium falciparum erythrocytic stage culture system

10.1186/s12936-015-0651-1 · 2015 · External reference

Volatile biomarkers of symptomatic and asymptomatic malaria infection in humans

10.1073/pnas.1801512115 · 2018 · External reference

Downregulation of plasma miR-451 and miR-16 in Plasmodium vivax infection

10.1016/j.exppara.2015.04.013 · 2015 · External reference

Comparative evaluation of plasma biomarkers of Schistosoma haematobium infection in endemic populations from Burkina Faso

10.1371/journal.pntd.0012104 · 2024 · External reference

Parasite-derived circulating microRNAs as biomarkers for the detection of human Schistosoma japonicum infection

10.1017/s0031182019001690 · 2020 · External reference

Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy

10.1186/1756-3305-6-272 · 2013 · External reference

Potential biomarkers for asymptomatic visceral leishmaniasis among Iraq-deployed U.S. military personnel

10.3390/pathogens12050705 · 2023 · External reference

Biomarkers of the early response to treatment of visceral leishmaniasis: a prospective cohort study

10.1111/pim.12797 · 2021 · External reference

Altered miRNA expression in the lesions of cutaneous leishmaniasis caused by L. major and L. tropica with insights into apoptosis regulation

10.1038/s41598-025-03802-1 · 2025 · External reference

Identification, selection and testing of new antigens for tegumentary Leishmaniasis serological diagnosis

10.1016/j.exppara.2026.109134 · 2026 · External reference

Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease

20242024 · External reference

Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patients

10.1371/journal.pntd.0013082 · 2025 · External reference

Exploring the diagnostic potential of parasite-derived miRNAs in cystic echinococcosis: are we getting closer?

2025 · External reference

Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis

10.1038/s41598-020-73265-z · 2020 · External reference

Differential expression of hsa-miR-144-3p and hsa-miR-125b-5p in gestational toxoplasmosis

10.1111/pim.70032 · 2025 · External reference

Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection

10.1186/s13071-016-1582-6 · 2016 · External reference

A novel antigen biomarker for detection of high-level of Loa loa microfilaremia

10.1371/journal.pntd.0012461 · 2024 · External reference

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination

10.1371/journal.pntd.0013146 · 2025 · External reference

Multiple biochemical indices and metabolomics of Clonorchis sinensis provide a novel interpretation of biomarkers

10.1186/s13071-022-05290-y · 2022 · External reference

2-Methyl-pentanoyl-carnitine (2-MPC): a urine biomarker for patent Ascaris lumbricoides infection

10.1038/s41598-020-72804-y · 2020 · External reference

Detection of ascaris lumbricoides infection by aba-1 coproantigen elisa

10.1371/journal.pntd.0008807 · 2020 · External reference

Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis

10.1186/s13071-020-04391-w · 2020 · External reference

Serum aca-mir-146a is a potential biomarker for early diagnosis of Angiostrongylus cantonensis infection

10.1007/s00436-014-3984-8 · 2014 · External reference

TvNTPDase4, a surface ectonucleotidase of Trichomonas vaginalis, is a potential immunological marker for the diagnosis of trichomoniasis in women

10.1016/j.micres.2026.128590 · 2026 · External reference

Giardia lamblia mirnas as a new diagnostic tool for human giardiasis

10.1371/journal.pntd.0007398 · 2019 · External reference

Neglected tropical diseases: recent trends and challenges associated with its rapid diagnosis and effective therapeutic strategies

10.3389/fphar.2026.1742086 · 2026 · External reference

CRISPR/Cas12a-RCA enables ultrasensitive detection of circulating free DNA for noninvasive diagnosis of echinococcosis

10.1371/journal.pntd.0013069 · 2026 · External reference

Performance of a smartphone-based malaria screener in detecting malaria in people living with Sickle cell disease

2025 · External reference

Microfluidic paper-based analytical device for point-of-care nucleic acid quantification of malaria

10.1016/j.microc.2025.113139 · 2025 · External reference

REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes

10.1038/s41564-018-0295-3 · 2019 · External reference

Challenges and opportunities of molecular epidemiology: using omics to address complex one health issues in tropical settings

10.3389/fitd.2023.1151336 · 2023 · External reference